Development of synthetic antigen vaccines for COVID-19
Authors:
- Maria da Conceição Viana InvençãoMIMaria da Conceição Viana Invenção
- Alanne Rayssa da Silva MeloAMAlanne Rayssa da Silva Melo
- Larissa Silva de MacêdoLarissa Silva de Macêdo
- Thaís Souto Paula da Costa NevesTNThaís Souto Paula da Costa Neves
- Cristiane Moutinho Lagos de MeloCMCristiane Moutinho Lagos de Melo
- Marcelo Nazário CordeiroMCMarcelo Nazário Cordeiro
- Marcus Vinicius de Aragão BatistaMarcus Vinicius de Aragão Batista
- Antonio Carlos de FreitasAntonio Carlos de Freitas
- 6 October 2021
- journal article
- other
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (11) , 3855-3870
Abstract
The current pandemic called COVID-19 caused by the SARS-CoV-2 virus brought the need for the search for fast alternatives to both control and fight the SARS-CoV-2 infection. Therefore, a race for a vaccine against COVID-19 took place, and some vaccines have been approved for emergency use in several countries in a record time. Ongoing prophylactic research has sought faster, safer, and precise alternatives by redirecting knowledge of other vaccines, and/or the development of new strategies using available tools, mainly in the areas of genomics and bioinformatics. The current review highlights the development of synthetic antigen vaccines, focusing on the usage of bioinformatics tools for the selection and construction of antigens on the different vaccine constructions under development, as well as strategies to optimize vaccines for COVID-19.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887-507421/2020-00)
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (PPSUS 2020 APQ-0260-2.02/20)
- Ministério Público do Trabalho de Pernambuco (Apoio ao Enfrentamento da COVID-19)
- Universidade Federal de Pernambuco (Edital PROPESQI 06/2020)
This publication has 137 references indexed in Scilit:
- Properties of MHC Class I Presented Peptides That Enhance ImmunogenicityPLOS Computational Biology, 2013
- NetCTLpan: pan-specific MHC class I pathway epitope predictionsImmunogenetics, 2010
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantJournal of Experimental Medicine, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus ApproachPLOS Computational Biology, 2008
- The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methodsVaccine, 2008
- A melanoma multiepitope polypeptide induces specific CD8+ T-cell responseCellular Immunology, 2007
- Large-scale validation of methods for cytotoxic T-lymphocyte epitope predictionBMC Bioinformatics, 2007
- Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccinesBMC Bioinformatics, 2007
- Exceptional Flexibility in the Sequence Requirements for Coronavirus Small Envelope Protein FunctionJournal of Virology, 2007